Free Trial

Ironwood Pharmaceuticals (IRWD) Insider Trading & Ownership

Ironwood Pharmaceuticals logo
$3.64 +0.12 (+3.41%)
(As of 03:27 PM ET)

Ironwood Pharmaceuticals (NASDAQ:IRWD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.90%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$160,419.92
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$4.70 M
Get IRWD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ironwood Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IRWD Insider Buying and Selling by Quarter

Ironwood Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/18/2024Andrew DavisSVPSell5,360$4.08$21,868.80  
11/18/2024Sravan Kumar EmanyCFOSell11,001$4.08$44,884.08  
8/12/2024Minardo JohnInsiderSell9,910$4.27$42,315.70  
6/10/2024Julie MchughDirectorSell22,766$6.29$143,198.14  
6/6/2024Catherine MoukheibirDirectorSell44,426$6.36$282,549.36  
3/6/2024Jon R DuaneDirectorBuy6,920$8.70$60,204.00  
3/4/2024Sravan Kumar EmanyCFOBuy10,684$9.38$100,215.92  
2/12/2024Andrew DavisSVPSell9,846$15.24$150,053.04  
2/12/2024Michael ShetzlineCMOSell38,618$15.24$588,538.32  
2/12/2024Minardo JohnInsiderSell47,380$15.24$722,071.20  
2/12/2024Thomas A MccourtCEOSell177,164$15.24$2,699,979.36  
(Data available from 1/1/2013 forward)

IRWD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Ironwood Pharmaceuticals includes Andrew Davis, Catherine Moukheibir, Jason Rickard, Jon R Duane, Julie Mchugh, Mark G Currie, Marla L Kessler, Michael Shetzline, Minardo John, Ronald Silver, Sravan Kumar Emany, and Thomas A Mccourt. Learn more on insiders at IRWD.

12.90% of Ironwood Pharmaceuticals stock is owned by insiders. Learn more on IRWD's insider holdings.

The following insiders have purchased IRWD shares in the last 24 months: Jon R Duane ($60,204.00), and Sravan Kumar Emany ($400,334.96).

Insiders have purchased a total of 53,676 IRWD shares in the last 24 months for a total of $460,538.96 bought.

The following insiders have sold IRWD shares in the last 24 months: Andrew Davis ($191,900.75), Catherine Moukheibir ($282,549.36), Jason Rickard ($191,071.86), Julie Mchugh ($143,198.14), Michael Shetzline ($696,568.20), Minardo John ($764,386.90), Ronald Silver ($33,419.89), Sravan Kumar Emany ($44,884.08), and Thomas A Mccourt ($5,762,129.25).

Insiders have sold a total of 665,996 Ironwood Pharmaceuticals shares in the last 24 months for a total of $8,110,108.43 sold.

Ironwood Pharmaceuticals Key Executives

  • Mr. Thomas A. McCourtMr. Thomas A. McCourt (Age 67)
    CEO & Director
    Compensation: $1.61M
  • Mr. Sravan Kumar Emany (Age 46)
    Senior VP, Principal Financial Officer & CFO
    Compensation: $913.88k
    1 recent trades
  • Mr. John Minardo (Age 48)
    Senior VP, Chief Legal Officer & Secretary
    Compensation: $814.41k
  • Dr. Michael Shetzline M.D. (Age 65)
    Ph.D., Chief Medical Officer, Senior VP and Head of Research & Drug Development
    Compensation: $860.45k
  • Mr. Andrew Davis (Age 37)
    Senior VP & Chief Business Officer
    Compensation: $824.36k
    1 recent trades
  • Mr. Ronald SilverMr. Ronald Silver (Age 41)
    Corporate Controller & Principal Accounting Officer
  • Mr. Marcel Moulaison
    Vice President of Technical Operations
  • Greg Martini
    Vice President of Strategic Finance & Investor Relations
  • Ms. Beth Calitri
    Head of Corporate Communications & Media Relations
  • Mr. Mike Nanfito
    Vice President of Sales & Sales Excellence


This page (NASDAQ:IRWD) was last updated on 11/27/2024 by MarketBeat.com Staff
From Our Partners